Relationship between Helicobacter pylori infection and metabolic syndrome

Turkish Journal of Gastroenterology

Volumn 26, Issue 6, 2015, Pages 468-473

  Sayilar, Emel Işiktaş ^a   Çelik, Bülent ^b   Dumlu, Şükrü ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Helicobacter pylori; Insulin resistance; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; DIAGNOSTIC PROCEDURE; DIASTOLIC BLOOD PRESSURE; ENDOSCOPY; FEMALE; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS; BLOOD; BLOOD PRESSURE; COMPLICATION; DIET RESTRICTION; INSULIN RESISTANCE; MICROBIOLOGY; PHYSIOLOGY; PREVALENCE; RISK FACTOR; AGE DISTRIBUTION; BACTERIUM DETECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPEPSIA; HOMEOSTASIS MODEL ASSESSMENT; HUMAN TISSUE; NONHUMAN;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; FASTING; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84946826239     PISSN: 13004948     EISSN: 21485607     Source Type: Journal    
DOI: 10.5152/tjg.2015.0197     Document Type: Article

References (29)

1. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010; 362: 1597-604. [CrossRef]
2. Vaira D, Gatta L, Ricci C, Miglioli M. Review article: diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16(Suppl 1): 16-23. [CrossRef]
3. Chey WD, Wong BC; Practice Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808-25. [CrossRef]
4. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005; 12: 295-300. [CrossRef]
5. Nabipour I, Vahdat K, Jafari SM, Pazoki R, Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study. Cardiovasc Diabetol 2006; 5: 25-30. [CrossRef]
6. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-9. [CrossRef]
7. Gunji T, Matsuhashi N, Sato H, et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 2008; 103: 3005-10. [CrossRef]
8. Arslan E, Atilgan H, Yavasoglu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med 2009; 20: 695-7. [CrossRef]
9. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J 2010; 103: 190-6. [CrossRef]
10. Eshraghian A, Hashemi SA, Hamidian Jahromi A, et al. Helicobacter pylori infection as a risk factor for insulin resistance. Dig Dis Sci 2009; 54: 1966-70. [CrossRef]
11. Aydemir S, Bayraktaroglu T, Sert M, et al. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci 2005; 50: 2090-3. [CrossRef]
12. Aslan M, Horoz M, Nazligul Y, et al. Insulin resistance in H pylori infection and its association with oxidative stress. World J Gastroenterol 2006; 12: 6865-8.
13. Gunji T, Matsuhashi N, Sato H, et al. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 2009; 14: 144-50. [CrossRef]
14. Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 2007; 121: 229-38. [CrossRef]
15. Kucukazman M, Yavuz B, Sacikara M, et al. The relationship between updated Sydney System score and LDL cholesterol levels in patients infected with Helicobacter pylori. Dig Dis Sci 2009; 54: 604-7. [CrossRef]
16. Sung KC, Rhee EJ, Ryu SH, Beck SH. Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol 2005; 102: 411-7. [CrossRef]
17. Hoffmeister A, Rothenbacher D, Bode G, et al. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol 2001; 21: 427-32. [CrossRef]
18. Takashima T, Adachi K, Kawamura A, et al. Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter 2002; 7: 86-90.[CrossRef]
19. Elizalde JI, Pique JM, Moreno V, et al. Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen. Aliment Pharmacol Ther 2002; 16: 577-86. [CrossRef]
20. Ando T, Minami M, Ishiguro K, et al. Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication. Aliment Pharmacol Ther 2006; 4: 58-64. [CrossRef]
21. Kanbay M, Gur G, Yucel M, Yilmaz U, Boyacioglu S. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 2005; 50: 1228-31. [CrossRef]
22. Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, Barresi G. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol 1996; 19: 149-54.
23. Kyriazanos ID, Sfiniadakis I, Gizaris V, et al. The incidence of Helicobacter pylori infection is not increased among obese young individuals in Greece. J Clin Gastroenterol 2002; 34: 541-6. [CrossRef]
24. Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ. Helicobacter pylori infection and endocrine disorders: is there a link? World J Gastroenterol 2009; 15: 2701-7. [CrossRef]
25. Gasbarrini A, Ojetti V, Pitocco D, et al. Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol 1998; 10: 469-72. [CrossRef]
26. Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci 2008; 53: 2646-9. [CrossRef]
27. Bener A, Micallef R, Afifi M, Derbala M, Al-Mulla HM, Usmani MA. Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol 2007; 18: 225-9.
28. Devrajani BR, Shah SZ, Soomro AA, Devrajani T. Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based casecontrol study. Int J Diabetes Dev Ctries 2010; 30: 22-6. [CrossRef]
29. Quadri R, Rossi C, Catalfamo E, et al. Helicobacter pylori infection in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2000; 10: 263-6.